Targeting the ATP Synthase in <i>Staphylococcus aureus </i>Small Colony Variants, <i>Streptococcus pyogenes </i>and Pathogenic Fungi
The ATP synthase has been validated as a druggable target with the approval of the ATP synthase inhibitor, bedaquiline, for treatment of drug-resistant <i>Mycobacterium tuberculosis</i>, a bacterial species in which the ATP synthase is essential for viability. Gene inactivation studies h...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-04-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/10/4/376 |